{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:34:42Z","timestamp":1780522482162,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["22\\u201317118S"],"award-info":[{"award-number":["22\\u201317118S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","award":["LX22NPO5103"],"award-info":[{"award-number":["LX22NPO5103"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118588","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:13:36Z","timestamp":1758629616000},"page":"118588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Bridging predictions with experimental reality: In vitro evaluation of phenolic natural products as SARS-CoV-2 exoribonuclease inhibitors"],"prefix":"10.1016","volume":"192","author":[{"given":"Mat\u011bj","family":"Danda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Chv\u00e1talov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ne\u010dasov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"K\u0159\u00ed\u017eov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5698-4366","authenticated-orcid":false,"given":"Tom\u00e1\u0161","family":"Ruml","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5645-8227","authenticated-orcid":false,"given":"Michaela","family":"Rumlov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118588_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.951725","article-title":"The natural iron chelators' ferulic acid and caffeic acid rescue mice's brains from side effects of iron overload","volume":"13","author":"AAlikhani","year":"2022","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118588_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/v15071539","article-title":"Analogs of the catechol derivative dynasore inhibit HIV-1 ribonuclease H, SARS-CoV-2 nsp14 exoribonuclease, and virus replication","volume":"15","author":"Asthana","year":"2023","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.biopha.2025.118588_bib3","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/nar\/gkab1303","article-title":"Characterization of the SARS-CoV-2 ExoN (nsp14-nsp10) complex: implications for its role in viral genome stability and inhibitor identification","volume":"50","author":"Baddock","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"24","key":"10.1016\/j.biopha.2025.118588_bib4","doi-asserted-by":"crossref","first-page":"9372","DOI":"10.1073\/pnas.1201130109","article-title":"RNA 3\u2032-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10\/nsp14 exoribonuclease complex","volume":"109","author":"Bouvet","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"13","key":"10.1016\/j.biopha.2025.118588_bib5","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1042\/BCJ20210198","article-title":"Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14\/nsp10 exoribonuclease","volume":"478","author":"Canal","year":"2021","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.biopha.2025.118588_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/v14071458","article-title":"Commercially available flavonols are better SARS-CoV-2 inhibitors than isoflavone and flavones","volume":"14","author":"Chaves","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.biopha.2025.118588_bib7","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1021\/acsptsci.1c00022","article-title":"Synergistic inhibition of SARS-CoV-2 replication using Disulfiram\/Ebselen and remdesivir","volume":"4","author":"Chen","year":"2021","journal-title":"Acs Pharmacol. Transl. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118588_bib8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsbiomedchemau.2c00046","article-title":"Substrate specificity and kinetics of RNA hydrolysis by SARS-CoV-2 NSP10\/14 exonuclease","volume":"2","author":"Dangerfield","year":"2022","journal-title":"Acs Bio Med Chem. Au"},{"issue":"4","key":"10.1016\/j.biopha.2025.118588_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043100","article-title":"Unveiling the potentiality of shikonin derivatives inhibiting SARS-CoV-2 main protease by molecular dynamic simulation studies","volume":"24","author":"Das","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118588_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s40203-023-00143-7","article-title":"Exploring the pharmacological aspects of natural phytochemicals against SARS-CoV-2 Nsp14 through an in silico approach","volume":"11","author":"De","year":"2023","journal-title":"Silico Pharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118588_bib11","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.biopha.2025.118588_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/01480545.2022.2152043","article-title":"Caffeic acid and ferulic acid can improve toxicological damage caused by iron overload mediated by carbonic anhydrase inhibition","volume":"47","author":"Figueredo","year":"2024","journal-title":"Drug Chem. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118588_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/acs.biochem.4c00490","article-title":"A High-Throughput screening pipeline to identify methyltransferase and exonuclease inhibitors of SARS-CoV-2 NSP14","volume":"64","author":"Hanson","year":"2025","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2025.118588_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105364","article-title":"Identification of potent inhibitors of arenavirus and SARS-CoV-2 exoribonucleases by fluorescence polarization assay","volume":"204","author":"Hernandez","year":"2022","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118588_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/nar\/gkac1207","article-title":"Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development","volume":"51","author":"Imprachim","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.118588_bib16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejmech.2019.01.018","article-title":"Medicinal chemistry of metal chelating fragments in metalloenzyme active sites: a perspective","volume":"165","author":"Jiang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"7811","key":"10.1016\/j.biopha.2025.118588_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.biopha.2025.118588_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103353","article-title":"Exploring the interaction of quercetin-3-O-sophoroside with SARS-CoV-2 main proteins by theoretical studies: a probable prelude to control some variants of coronavirus including delta","volume":"14","author":"Khan","year":"2021","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.biopha.2025.118588_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.647693","article-title":"Combining SARS-CoV-2 proofreading exonuclease and RNA-Dependent RNA polymerase inhibitors as a strategy to combat COVID-19: a High-Throughput in silico screening [Original Research]","volume":"12","author":"Khater","year":"2021","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118588_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1039\/D1CB00135C","article-title":"Identification of fragments binding to SARS-CoV-2 nsp10 reveals ligand-binding sites in conserved interfaces between nsp10 and nsp14\/nsp16","volume":"3","author":"Kozielski","year":"2022","journal-title":"RSC Chem. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118588_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.biopha.2025.118588_bib22","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1093\/nar\/gkab320","article-title":"Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity","volume":"49","author":"Lin","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"16","key":"10.1016\/j.biopha.2025.118588_bib23","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","article-title":"Structure-Based virtual screening for drug discovery: principles, applications and recent advances","volume":"14","author":"Lionta","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"issue":"6559","key":"10.1016\/j.biopha.2025.118588_bib24","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1126\/science.abi9310","article-title":"Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme","volume":"373","author":"Liu","year":"2021","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biopha.2025.118588_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jpha.2020.08.002","article-title":"Potential treatment with Chinese and Western Medicine targeting NSP14 of SARS-CoV-2","volume":"11","author":"Liu","year":"2021","journal-title":"J. Pharm. Anal."},{"issue":"2","key":"10.1016\/j.biopha.2025.118588_bib26","article-title":"Thermal unfolding methods in drug discovery","volume":"4","author":"Llowarch","year":"2023","journal-title":"Biophys. Rev. (Melville)"},{"key":"10.1016\/j.biopha.2025.118588_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2021.105894","article-title":"Reconstitution and functional characterization of SARS-CoV-2 proofreading complex","volume":"185","author":"Ma","year":"2021","journal-title":"Protein Expr. Purif."},{"issue":"11","key":"10.1016\/j.biopha.2025.118588_bib28","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1093\/nar\/gkae165","article-title":"Despite the odds: formation of the SARS-CoV-2 methylation complex","volume":"52","author":"Matsuda","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.biopha.2025.118588_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2106379119","article-title":"Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN","volume":"119","author":"Moeller","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"16","key":"10.1016\/j.biopha.2025.118588_bib30","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1039\/D0CS01065K","article-title":"A critical overview of computational approaches employed for COVID-19 drug discovery","volume":"50","author":"Muratov","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2025.118588_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2020.05.184","article-title":"High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment","volume":"160","author":"Naik","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"23","key":"10.1016\/j.biopha.2025.118588_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01246-20","article-title":"The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2","volume":"94","author":"Ogando","year":"2020","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118588_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.12793\/tcp.2019.27.2.59","article-title":"A review of computational drug repurposing","volume":"27","author":"Park","year":"2019","journal-title":"Transl. Clin. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2025.118588_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054401","article-title":"Lessons learnt from COVID-19: computational strategies for facing present and future pandemics","volume":"24","author":"Pavan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.biopha.2025.118588_bib35","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera - a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2025.118588_bib36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41557-019-0234-9","article-title":"Computational advances in combating colloidal aggregation in drug discovery","volume":"11","author":"Reker","year":"2019","journal-title":"Nat. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118588_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101518","article-title":"Activation of the SARS-CoV-2 NSP14 3\u2032-5\u2032 exoribonuclease by NSP10 and response to antiviral inhibitors","volume":"298","author":"Riccio","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.biopha.2025.118588_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197375","article-title":"Crystal structure of Non-Structural protein 10 from severe acute respiratory syndrome Coronavirus-2","volume":"21","author":"Rogstam","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118588_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41418-021-00900-1","article-title":"The NSP14\/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target","volume":"29","author":"Rona","year":"2022","journal-title":"Cell Death Differ."},{"issue":"W1","key":"10.1016\/j.biopha.2025.118588_bib40","doi-asserted-by":"crossref","first-page":"W463","DOI":"10.1093\/nar\/gkaf361","article-title":"PLIP 2025: introducing protein-protein interactions to the protein-ligand interaction profiler","volume":"53","author":"Schake","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.118588_bib41","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jff.2015.06.018","article-title":"Phenolics and polyphenolics in foods, beverages and spices: antioxidant activity and health effects - a review","volume":"18","author":"Shahidi","year":"2015","journal-title":"J. Funct. Foods"},{"issue":"8","key":"10.1016\/j.biopha.2025.118588_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003565","article-title":"Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics","volume":"9","author":"Smith","year":"2013","journal-title":"PLOS Pathog."},{"issue":"7","key":"10.1016\/j.biopha.2025.118588_bib43","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1002\/jmv.27009","article-title":"Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target","volume":"93","author":"Tahir","year":"2021","journal-title":"J. Med Virol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118588_bib44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Software news and update AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118588_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jtcme.2021.12.002","article-title":"Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamics simulations","volume":"12","author":"Vardhan","year":"2022","journal-title":"J. Tradit. Complement Med."},{"key":"10.1016\/j.biopha.2025.118588_bib46","first-page":"1","article-title":"Effectiveness of drug repurposing and natural products against SARS-CoV-2: a comprehensive review","volume":"16","author":"Vel\u00e1squez","year":"2024","journal-title":"Clin. Pharmacol. Adv. Appl."},{"issue":"3","key":"10.1016\/j.biopha.2025.118588_bib47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V'kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2025.118588_bib48","unstructured":"WHO. (2023). Statement on the Fifteenth Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Coronavirus Disease (COVID-19) Pandemic. Retrieved 18.12.2024 from \u3008https:\/\/www.who.int\/news\/item\/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations\u3009-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic?adgroupsurvey=%7Badgroupsurvey%7D&gclid=EAIaIQobChMI4Ojtsdbe_gIVjQRyCh07igt4EAAYASACEgJ9pfD_BwE&fbclid=IwAR2M8EAyiSrAodhK9p-X582nHkP2AigpSX8pYIsLsPwqYh4SG26RGokGe7E."},{"issue":"13","key":"10.1016\/j.biopha.2025.118588_bib49","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1016\/j.cell.2021.05.033","article-title":"Coupling of N7-methyltransferase and 3\u2032-5\u2032 exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading","volume":"184","author":"Yan","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2025.118588_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01253-21","article-title":"Structure-Based discovery and structural basis of a novel Broad-Spectrum natural product against the main protease of coronavirus","volume":"96","author":"Zhang","year":"2022","journal-title":"J. Virol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:39:28Z","timestamp":1775781568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225007826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"alternative-id":["S0753332225007826"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118588","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging predictions with experimental reality: In vitro evaluation of phenolic natural products as SARS-CoV-2 exoribonuclease inhibitors","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118588"}}